O POTENCIAL DO FUNDO DE DESENVOLVIMENTO DA AMAZÔNIA NO FOMENTO À PESQUISA, DESENVOLVIMENTO E TECNOLOGIA DO CENTRO DE BIONEGÓCIOS DA AMAZÔNIA

Abstract

The article aims to present the Amazon Development Fund (FDA) as a possible agent for the promotion of science, technology and innovation (ST&I) capable of providing financial resources to the Amazon Biobusiness Center (CBA), highlighting legal points that need to be suppressed, amended or created for legislative improvement, aiming at strategic partnerships between the FDA and CBA. One of the FDA's allocation forecasts is that a part of the proceeds from the return on the operations of financing granted will be allocated to support research, development and technology activities of interest to regional development. This is in line with the objectives of the CBA. It is understood that the conservation of biodiversity, development of sustainable technologies, generation of scientific knowledge and training and stimulation of innovation and entrepreneurship are important for the Amazon region and this is the pillar that supports the CBA. The legislative obstacles that may hinder the above-mentioned partnership are analysed. The study shows that although the funding procedure involves many actors, which can make its implementation complex, bureaucratic and slow, possible solutions to the FDA's legislative obstacles were pointed out, which can make its full potential viable and be an important instrument for promoting ST&I in the Amazon region, favoring the institutions and especially the CBA.